Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$0.45 - $0.86 $888 - $1,697
-1,974 Reduced 0.51%
388,759 $202,000
Q3 2022

Nov 14, 2022

SELL
$0.46 - $0.63 $10,072 - $13,794
-21,896 Reduced 5.31%
390,733 $176,000
Q2 2022

Aug 15, 2022

BUY
$0.47 - $0.87 $36,543 - $67,645
77,753 Added 23.22%
412,629 $239,000
Q1 2022

May 16, 2022

BUY
$0.75 - $1.77 $151,770 - $358,177
202,360 Added 152.71%
334,876 $264,000
Q4 2021

Feb 14, 2022

SELL
$1.56 - $2.93 $12,519 - $23,513
-8,025 Reduced 5.71%
132,516 $215,000
Q3 2021

Nov 15, 2021

BUY
$2.91 - $4.83 $13,546 - $22,483
4,655 Added 3.43%
140,541 $422,000
Q2 2021

Aug 17, 2021

SELL
$4.17 - $5.74 $2.58 Million - $3.55 Million
-618,181 Reduced 81.98%
135,886 $635,000
Q1 2021

May 17, 2021

BUY
$5.28 - $9.64 $839,013 - $1.53 Million
158,904 Added 26.7%
754,067 $3.98 Million
Q4 2020

Feb 16, 2021

BUY
$5.75 - $7.13 $657,949 - $815,857
114,426 Added 23.8%
595,163 $3.88 Million
Q3 2020

Nov 16, 2020

SELL
$4.9 - $7.12 $54,037 - $78,519
-11,028 Reduced 2.24%
480,737 $2.94 Million
Q2 2020

Aug 14, 2020

SELL
$6.43 - $9.86 $1.28 Million - $1.97 Million
-199,843 Reduced 28.9%
491,765 $3.57 Million
Q1 2020

May 15, 2020

BUY
$6.36 - $10.05 $255,036 - $403,005
40,100 Added 6.15%
691,608 $4.81 Million
Q4 2019

Feb 14, 2020

SELL
$8.49 - $12.81 $673,443 - $1.02 Million
-79,322 Reduced 10.85%
651,508 $5.75 Million
Q3 2019

Nov 14, 2019

BUY
$5.58 - $14.47 $1.21 Million - $3.13 Million
216,541 Added 42.1%
730,830 $8.19 Million
Q2 2019

Aug 14, 2019

SELL
$5.22 - $9.08 $172,625 - $300,275
-33,070 Reduced 6.04%
514,289 $3.12 Million
Q1 2019

May 15, 2019

BUY
$5.35 - $9.82 $96,637 - $177,378
18,063 Added 3.41%
547,359 $4.31 Million
Q4 2018

Feb 14, 2019

BUY
$3.43 - $6.19 $1.82 Million - $3.28 Million
529,296 New
529,296 $2.63 Million

Others Institutions Holding LCI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About LANNETT CO INC


  • Ticker LCI
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 42,960,000
  • Market Cap $1.29M
  • Description
  • Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nas...
More about LCI
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.